Analyst Price Target is $10.00
▲ +495.24% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Aethlon Medical in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 495.24% upside from the last price of $1.68.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Aethlon Medical. This Buy consensus rating has held steady for over two years.
Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.
Read More